Avecho Biotechnology Ltd (AVE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avecho Biotechnology Ltd (AVE) has a cash flow conversion efficiency ratio of -0.026x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-49.47K ≈ $-35.00K USD) by net assets (AU$1.91 Million ≈ $1.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Avecho Biotechnology Ltd for the company's overall valuation and market capitalisation.
Avecho Biotechnology Ltd - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how Avecho Biotechnology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Avecho Biotechnology Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avecho Biotechnology Ltd ranked by their cash flow conversion efficiency. Explore AVE cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Y/KNOT S.A.
AT:YKNOT
|
N/A |
|
Byuksan Corp
KO:007210
|
0.029x |
|
Sukhjit Starch & Chemicals Limited
NSE:SUKHJITS
|
-0.146x |
|
Chips&Media Inc
KQ:094360
|
0.065x |
|
High Roller Technologies, Inc.
NYSE MKT:ROLR
|
-0.012x |
|
Mistral Gayrimenkul Yatirim Ortakligi AS
IS:MSGYO
|
-0.005x |
|
Big Sunshine Co Ltd
TW:1475
|
0.037x |
|
Pollux Properti Indonesia Tbk PT
JK:POLL
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Avecho Biotechnology Ltd (1993–2025)
The table below shows the annual cash flow conversion efficiency of Avecho Biotechnology Ltd from 1993 to 2025. View AVE stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | AU$1.56 Million ≈ $1.10 Million |
AU$1.10 Million ≈ $780.51K |
0.707x | +158.27% |
| 2024-12-31 | AU$3.27 Million ≈ $2.31 Million |
AU$-3.97 Million ≈ $-2.81 Million |
-1.214x | -143.44% |
| 2023-12-31 | AU$6.38 Million ≈ $4.51 Million |
AU$-3.18 Million ≈ $-2.25 Million |
-0.499x | +27.39% |
| 2022-12-31 | AU$2.42 Million ≈ $1.72 Million |
AU$-1.67 Million ≈ $-1.18 Million |
-0.687x | -0.54% |
| 2021-12-31 | AU$4.54 Million ≈ $3.21 Million |
AU$-3.10 Million ≈ $-2.19 Million |
-0.683x | -27.40% |
| 2020-12-31 | AU$2.65 Million ≈ $1.88 Million |
AU$-1.42 Million ≈ $-1.01 Million |
-0.536x | -314.63% |
| 2019-12-31 | AU$4.76 Million ≈ $3.37 Million |
AU$1.19 Million ≈ $841.16K |
0.250x | +144.53% |
| 2018-12-31 | AU$3.90 Million ≈ $2.76 Million |
AU$-2.19 Million ≈ $-1.55 Million |
-0.561x | +44.06% |
| 2017-12-31 | AU$6.40 Million ≈ $4.53 Million |
AU$-6.42 Million ≈ $-4.54 Million |
-1.003x | -82.12% |
| 2016-12-31 | AU$11.65 Million ≈ $8.24 Million |
AU$-6.41 Million ≈ $-4.54 Million |
-0.551x | -82.97% |
| 2015-12-31 | AU$28.93 Million ≈ $20.47 Million |
AU$-8.71 Million ≈ $-6.16 Million |
-0.301x | -118.93% |
| 2014-12-31 | AU$49.03 Million ≈ $34.69 Million |
AU$-6.74 Million ≈ $-4.77 Million |
-0.137x | +34.67% |
| 2013-12-31 | AU$40.77 Million ≈ $28.85 Million |
AU$-8.58 Million ≈ $-6.07 Million |
-0.210x | -12.95% |
| 2012-12-31 | AU$62.61 Million ≈ $44.30 Million |
AU$-11.66 Million ≈ $-8.25 Million |
-0.186x | -46.22% |
| 2011-12-31 | AU$72.95 Million ≈ $51.61 Million |
AU$-9.29 Million ≈ $-6.58 Million |
-0.127x | +40.42% |
| 2010-12-31 | AU$39.01 Million ≈ $27.60 Million |
AU$-8.34 Million ≈ $-5.90 Million |
-0.214x | -19.25% |
| 2009-12-31 | AU$49.99 Million ≈ $35.37 Million |
AU$-8.96 Million ≈ $-6.34 Million |
-0.179x | -27.81% |
| 2008-12-31 | AU$51.55 Million ≈ $36.48 Million |
AU$-7.23 Million ≈ $-5.12 Million |
-0.140x | -72.82% |
| 2007-12-31 | AU$133.76 Million ≈ $94.65 Million |
AU$-10.86 Million ≈ $-7.68 Million |
-0.081x | -35.51% |
| 2006-12-31 | AU$135.47 Million ≈ $95.86 Million |
AU$-8.12 Million ≈ $-5.74 Million |
-0.060x | -73.92% |
| 2005-12-31 | AU$132.14 Million ≈ $93.50 Million |
AU$-4.55 Million ≈ $-3.22 Million |
-0.034x | -187.04% |
| 2004-12-31 | AU$113.22 Million ≈ $80.11 Million |
AU$-1.36 Million ≈ $-961.27K |
-0.012x | +57.60% |
| 2003-12-31 | AU$29.38 Million ≈ $20.79 Million |
AU$-831.60K ≈ $-588.41K |
-0.028x | +53.36% |
| 2002-12-31 | AU$14.81 Million ≈ $10.48 Million |
AU$-898.56K ≈ $-635.79K |
-0.061x | -18.47% |
| 2001-12-31 | AU$18.34 Million ≈ $12.98 Million |
AU$-939.40K ≈ $-664.68K |
-0.051x | -29.20% |
| 2000-12-31 | AU$20.67 Million ≈ $14.63 Million |
AU$-819.60K ≈ $-579.92K |
-0.040x | +41.04% |
| 1999-12-31 | AU$5.02 Million ≈ $3.55 Million |
AU$-337.79K ≈ $-239.01K |
-0.067x | +73.74% |
| 1998-12-31 | AU$1.59 Million ≈ $1.12 Million |
AU$-406.45K ≈ $-287.59K |
-0.256x | +63.11% |
| 1997-12-31 | AU$5.45 Million ≈ $3.86 Million |
AU$-3.78 Million ≈ $-2.68 Million |
-0.694x | -540.59% |
| 1996-12-31 | AU$27.18 Million ≈ $19.23 Million |
AU$-2.94 Million ≈ $-2.08 Million |
-0.108x | -118.58% |
| 1995-12-31 | AU$28.90 Million ≈ $20.45 Million |
AU$-1.43 Million ≈ $-1.01 Million |
-0.050x | +56.02% |
| 1994-12-31 | AU$10.81 Million ≈ $7.65 Million |
AU$-1.22 Million ≈ $-862.52K |
-0.113x | -5205.41% |
| 1993-12-31 | AU$10.42 Million ≈ $7.37 Million |
AU$23.00K ≈ $16.27K |
0.002x | -- |
About Avecho Biotechnology Ltd
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic f… Read more